Clinical Pharmacy

For most of the history of pharmacy, the pharmacist's job was defined by the product: compounding a mixture, weighing a powder, rolling a pill, and handing over a bottle with instructions.

8 frameworks, from 1960 to today · Pharmacy · Medicine & Health

still a working view ended · each leads to its entry below

Overview

For most of the history of pharmacy, the pharmacist's job was defined by the product: compounding a mixture, weighing a powder, rolling a pill, and handing over a bottle with instructions. The prescriber made the decision; the pharmacist executed it. Clinical pharmacy is the movement that changed this. It redefined the pharmacist as a professional whose primary concern is the patient and the outcome of drug therapy, not merely the accurate preparation and delivery of a product. A clinical pharmacist reviews a patient's full medication regimen, asks whether each drug is indicated, dosed correctly for that person's kidneys and liver, and whether it interacts dangerously with the rest. The field's central insight is that most medication problems are not manufacturing failures but decisions—wrong drug, wrong dose, wrong duration—and that someone with pharmacological training needs to be present where those decisions get made.

The Mid-Century Hospital as the Cradle

Clinical pharmacy emerged in the United States in the 1950s and 1960s, first inside hospitals. Before then, hospital pharmacists mostly managed inventories and manufactured bulk preparations in the basement pharmacy. The rise of manufactured drugs after the Second World War—antibiotics, antihypertensives, corticosteroids—meant that hospitals no longer needed to compound much, and the pharmacist's traditional skills risked becoming marginal. At the same time, the number of drugs available exploded, drug interactions became a real clinical concern, and prescribing errors in hospitals were increasingly visible.

A key institutional step was the creation of hospital pharmacy residency programmes and the founding of the American Society of Hospital Pharmacists (1942), which later pushed for the pharmacist's clinical role. In the 1960s a few hospital pharmacists began attending ward rounds alongside physicians, offering drug information at the point of prescribing. The University of Kentucky and the University of California, San Francisco, were among the early sites where such "clinical" roles were formalised in the 1960s and 1970s. The term clinical pharmacy was in use by the mid-1960s to mark this shift from product to patient.

The Clinical Pharmacy Movement and Pharmaceutical Care

The movement needed a philosophy. In 1975, the Millis Commission report, sponsored by the American Association of Colleges of Pharmacy, argued that pharmacy education should train pharmacists as clinicians and that the profession should orient itself toward patient care. Pharmacy schools responded by adding clinical coursework, patient-contact rotations, and eventually the Doctor of Pharmacy (PharmD) as the entry degree in the United States, replacing the bachelor's-level BSc in Pharmacy by the early 2000s.

The defining theoretical statement came in 1990, when Charles Hepler and Linda Strand published "Opportunities and Responsibilities in Pharmaceutical Care."1 Their concept, pharmaceutical care, declared that the practitioner's responsibility is to ensure that drug therapy achieves defined therapeutic goals that improve a patient's quality of life, and that the pharmacist shares accountability for that outcome1. The idea is deceptively simple but radical: it makes the pharmacist responsible for results, not just for accuracy at the counter. The American Society of Health-System Pharmacists adopted the concept in 1993, and pharmaceutical care became the profession's guiding language worldwide. Between 1995 and 2000 the International Pharmaceutical Federation (FIP) promoted it globally, and in 1997 a group of European pharmacy organisations issued the Granada statement on the pharmacist's role in health care.

Clinical Pharmacokinetics and Therapeutic Drug Monitoring

To be trusted with dosing, pharmacists needed a quantitative science of the body's handling of drugs—clinical pharmacokinetics: the study of how a drug is absorbed, distributed, metabolised, and eliminated in patients2. The four parameters at its core are clearance (the volume of blood cleared of drug per unit time), volume of distribution (the apparent space the drug occupies), half-life (the time for blood concentration to halve), and bioavailability (the fraction of a dose reaching the bloodstream intact). These made it possible to predict how a dose should change when a patient's kidney function fails or when another drug speeds or slows metabolism.

Therapeutic drug monitoring (TDM) is the practical companion: measuring drug concentrations in blood at defined times and adjusting the dose to keep the patient within a therapeutic window3. It matters most for drugs where the gap between helpful and harmful is narrow—digoxin, phenytoin, lithium, the aminoglycoside antibiotics, and later the immunosuppressants cyclosporine and tacrolimus, and the antiepileptic vancomycin's counterpart gentamicin. Formal pharmacokinetic consult services staffed by pharmacists appeared in the 1970s and 1980s; Bayesian dose-prediction software that combines population data with a patient's measured levels arrived later and improved individualisation.

From Error Counting to Medication Safety

Parallel to this came medication safety: the study and prevention of medication errors and adverse drug events. The field's landmark study was published in 1991 by Lucian Leape and colleagues—the Harvard Medical Practice Study analysis of medication errors in two Boston hospitals—which documented that adverse drug events were common and that most arose from errors in prescribing and administration rather than in dispensing. Earlier, in 1961, the UK's British Medical Journal case series by E. A. Barker and colleagues and the work of others had started to count errors systematically, but it was the 1990s that turned this into a discipline.

Two ideas reshaped the field. One was high-alert medications—drug classes such as anticoagulants, insulin, opioids, and concentrated electrolytes that cause disproportionate harm when misused, and which require special handling. The other was systems thinking: that errors are usually caused by faulty processes, not careless individuals, a view made famous by the Institute of Medicine's 1999 report To Err Is Human. Pharmacists became central to safety reforms—medication reconciliation at admission and discharge, standardised hospital order sets, unit-dose packaging, computerised prescriber order entry with clinical decision support, and the Swiss cheese model of layered defences. Today no hospital pharmacy department is without a drug use safety programme.

The Hospital Ward Reaches Out: Clinical Practice and Evidence

By the 1990s and 2000s clinical pharmacy had expanded beyond the hospital pharmacy and into specialty roles. Ward-based clinical pharmacists, critical care pharmacists, oncology and transplant pharmacists, and ambulatory clinic pharmacists became common. The pharmacist's tools shifted toward evidence-based clinical pharmacy: querying the primary literature and systematic reviews to answer bedside drug questions, and applying tools like the Cochrane Library and formal evidence grading (e.g. GRADE) to prescribing decisions. Pharmacy-based literature evaluation became a taught skill, and formulary management—deciding which agents a hospital or health system stocks and how—became a clinical responsibility with economic stakes.

Antimicrobial stewardship is the clearest example of a distinctive clinical pharmacy practice4. The rise of antibiotic resistance, recognised with force in the 1990s, pushed hospitals to create stewardship teams to monitor prescribing, restrict broad-spectrum agents, de-escalate therapy based on culture results, and link the right drug and dose to the right duration. Pharmacists lead many of these programmes today. The shift from "the pharmacist dispenses" to "the pharmacist guides therapy" is nowhere more visible than here.

Deprescribing and the Current Frontier

The newest turn is deprescribing: the deliberate, supervised withdrawal of medicines that are no longer appropriate5. It arrived with the ageing of populations and the recognition that many older patients are on long lists of drugs—polypharmacy—that accumulate over years and produce harm through interactions and adverse effects. Related movements in geriatric medicine (the Beers Criteria, first published in 1991, and the STOPP/START criteria from Ireland, 2008) gave clinicians explicit lists of inappropriate medications for older people. Deprescribing asks not simply whether a drug is appropriate but whether its indication still exists, whether its benefit now outweighs its burden, and what tapering is safe5. It is a natural extension of pharmaceutical care: if the pharmacist is accountable for outcomes, that must include the outcome of stopping.

References

  1. Pharmaceutical care (History), Wikipedia
  2. Pharmacokinetics, Wikipedia
  3. Therapeutic drug monitoring, Wikipedia
  4. Antimicrobial stewardship, Wikipedia
  5. Deprescribing, Wikipedia

The frameworks of Clinical Pharmacy

Each framework is a way of working the field has used: when it held, and the question it answers.

  1. 1960-Present

    Clinical Pharmacy Movement

    Should the pharmacist focus on the patient rather than the product?

    Fly to its tower in Nousfarer

  2. 1970-Present

    Clinical Pharmacokinetics

    How does the body handle a drug over time?

    Fly to its tower in Nousfarer

  3. 1975-Present

    Therapeutic Drug Monitoring

    How should a dose be adjusted to a measured drug level?

    Fly to its tower in Nousfarer

  4. 1990-Present

    Pharmaceutical Care

    Who is accountable for the outcome of drug therapy?

    Fly to its tower in Nousfarer

  5. 1991-Present

    Medication Safety and Systems Thinking

    Why do medication errors happen and how can they be prevented?

    Fly to its tower in Nousfarer

  6. 1995-Present

    Antimicrobial Stewardship

    How should antibiotic use be guided to preserve their power?

    Fly to its tower in Nousfarer

  7. 1995-Present

    Evidence-Based Clinical Pharmacy

    How should evidence be used to answer a bedside drug question?

    Fly to its tower in Nousfarer

  8. 2008-Present

    Deprescribing

    When and how should a medicine be stopped?

    Fly to its tower in Nousfarer

How the ideas connect

Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.

Clinical Pharmacy MovementClinical PharmacokineticsTherapeutic Drug MonitoringPharmaceutical CareMedication Safety and Systems ThinkingAntimicrobial StewardshipEvidence-Based Clinical PharmacyDeprescribing

Beyond the field

Where Clinical Pharmacy's ideas came from in other fields, and what they led to there: the strongest 12 of 49 links.

A city in Nousfarer: a red-carpeted stair climbing terraces to a crowned tower on an acropolis, more towers round it, forest and snowy mountains beyond.
A city in Nousfarer, the game played in the browser.

Clinical Pharmacy is a planet in Nousfarer

Its city has a tower for each of these 8 frameworks. Land, walk in, and climb one concept at a time.

Land on Clinical Pharmacy

Related fields

Fields its ideas are linked to

More in Pharmacy

See where Clinical Pharmacy sits on the Map of Human Knowledge